Preparations
- 10 Dec 2023
- 1 Minute to read
- Print
- PDF
Preparations
- Updated on 10 Dec 2023
- 1 Minute to read
- Print
- PDF
Article summary
Did you find this summary helpful?
Thank you for your feedback
The different options for testosterone prescribing include:
- Testogel sachets (2.5g containing 40.5mg testosterone).
- Tostran (2% testosterone gel in a canister containing 60g).
- Testim tubes (1% testosterone gel in a 5ml tube).
- Androfeme cream (1% testosterone cream in a 50ml tube). Only available in the private sector.
For dosing regimes, see prescribing information section.
- There are no licensed testosterone products for female use in the UK.
- Licensed male testosterone preparations such as Testogel, Tostran and Testim can be used, off-license, at lower doses in females (the recommended daily testosterone dose in females is 5mg).
- This is backed by national guidance and meets the criteria proposed by the GMC and MHRA on prescribing an unlicensed medicine.
- Androfeme is licensed in Australia for female use. However, it is not available on the NHS. It is only available in the private sector.
- Depending on local prescribing regulations testosterone prescribing may be limited to clinicians with expertise in menopause.
- Patients should be made aware of this information.
- Tibolone is a continuous combined HRT that is weakly androgenic, progestogenic and oestrogenic. It can be an alternative.
Note:
- It is important that any symptoms of vulvovaginal atrophy are adequately treated if testosterone is being prescribed.
- Oral testosterone is not recommended.
References and Further Information:
- Davis S, Baber R, Panay N et al. Global consensus statement on the use of testosterone therapy for women. Climacteric 2019.
- British Menopause Society. Tools for clinicians. Testosterone replacement in menopause. December 2022.
- BMS statement on testosterone. British Menopause Society. March 2023.
- Cooper C and Gray S. Top tips on testosterone use for women. Primary Care Women’s Health Forum. May 2022.
- Menopause Practice Standards produced by the British Menopause Society (BMS), Royal College of Obstetricians and Gynaecologists (RCOG), Society for Endocrinology (SfE), Faculty of Sexual and Reproductive Health (FSRH), Faculty of Pharmaceutical Medicine (FPM) and Royal Pharmaceutical Society (RPS) 2022. Standard 7.
Was this article helpful?